| Item Type | Name |
|
Academic Article
|
Parkinson's disease: recent advances in therapy.
|
|
Academic Article
|
Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy.
|
|
Academic Article
|
Botulinum A toxin in the treatment of blepharospasm.
|
|
Academic Article
|
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
|
|
Academic Article
|
Outcome after stereotactic thalamotomy for dystonia and hemiballismus.
|
|
Academic Article
|
Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia.
|
|
Academic Article
|
Clozapine for acute and maintenance treatment of psychosis in Parkinson's disease.
|
|
Academic Article
|
Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor.
|
|
Academic Article
|
Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome.
|
|
Academic Article
|
[Medial posteroventral pallidotomy for the treatment of Parkinson's disease].
|
|
Academic Article
|
Microelectrode-guided posteroventral pallidotomy for treatment of Parkinson's disease: postoperative magnetic resonance imaging analysis.
|
|
Academic Article
|
Clinical correlates of vascular parkinsonism.
|
|
Academic Article
|
New and emerging therapies for Parkinson disease.
|
|
Academic Article
|
Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
|
|
Academic Article
|
Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor.
|
|
Academic Article
|
A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor.
|
|
Academic Article
|
Thalamic deep brain stimulation: comparison between unilateral and bilateral placement.
|
|
Academic Article
|
Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease.
|
|
Academic Article
|
Parkinson's disease therapy: treatment of early and late disease.
|
|
Academic Article
|
A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease.
|
|
Academic Article
|
Tetrabenazine treatment for Huntington's disease-associated chorea.
|
|
Academic Article
|
Thalamic surgery for movement disorders.
|
|
Academic Article
|
Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease.
|
|
Academic Article
|
Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
|
|
Academic Article
|
Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
|
|
Academic Article
|
Long-term efficacy of posteroventral pallidotomy in the treatment of Parkinson's disease.
|
|
Academic Article
|
Benefits and risks of pharmacological treatments for essential tremor.
|
|
Academic Article
|
Parkinson's disease therapy: tailoring choices for early and late disease, young and old patients.
|
|
Academic Article
|
Pallidotomy for generalized dystonia.
|
|
Academic Article
|
Posteroventral medial pallidotomy for treatment of Parkinson's disease: preoperative magnetic resonance imaging features and clinical outcome.
|
|
Academic Article
|
Concepts and methods in chronic thalamic stimulation for treatment of tremor: technique and application.
|
|
Academic Article
|
Medical therapy and botulinum toxin in dystonia.
|
|
Academic Article
|
Comparison of thalamotomy and pallidotomy for the treatment of dystonia.
|
|
Academic Article
|
Hemifacial spasm: clinical findings and treatment.
|
|
Academic Article
|
Movement and reaction times and fine coordination tasks following pallidotomy.
|
|
Academic Article
|
Basal ganglia neuronal discharge in primary and secondary dystonia.
|
|
Academic Article
|
Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol.
|
|
Academic Article
|
Effects of visual and auditory cues on gait in individuals with Parkinson's disease.
|
|
Academic Article
|
Botulinum toxin in the treatment of tics.
|
|
Academic Article
|
Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Evidence-based review of patient-reported outcomes with botulinum toxin type A.
|
|
Academic Article
|
An open-label pilot study of levetiracetam for essential tremor.
|
|
Academic Article
|
Postural control in Parkinson's disease after unilateral posteroventral pallidotomy.
|
|
Academic Article
|
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
|
|
Academic Article
|
Switching from pergolide to pramipexole in patients with Parkinson's disease.
|
|
Academic Article
|
Tourette's syndrome.
|
|
Academic Article
|
Thalamic deep brain stimulation: effects on the nontarget limbs.
|
|
Academic Article
|
Camptocormia: pathogenesis, classification, and response to therapy.
|
|
Academic Article
|
Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.
|
|
Academic Article
|
Topiramate in essential tremor: a double-blind, placebo-controlled trial.
|
|
Academic Article
|
Effect of vagal nerve stimulation in a case of Tourette's syndrome and complex partial epilepsy.
|
|
Academic Article
|
Treatment of dystonia.
|
|
Academic Article
|
GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities.
|
|
Academic Article
|
The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor.
|
|
Academic Article
|
Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis.
|
|
Academic Article
|
Potential therapeutic properties of green tea polyphenols in Parkinson's disease.
|
|
Academic Article
|
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
|
|
Academic Article
|
Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?
|
|
Academic Article
|
Symptomatic treatment of Huntington disease.
|
|
Academic Article
|
Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease.
|
|
Academic Article
|
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
|
|
Academic Article
|
Role of botulinum toxin in the treatment of cervical dystonia.
|
|
Academic Article
|
Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism.
|
|
Academic Article
|
Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy.
|
|
Academic Article
|
Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration.
|
|
Academic Article
|
Advances in the pharmacological management of Huntington's disease.
|
|
Academic Article
|
Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease.
|
|
Academic Article
|
Globus pallidus deep brain stimulation in dystonia.
|
|
Academic Article
|
Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial.
|
|
Academic Article
|
Diagnosis and treatment of complications related to deep brain stimulation hardware.
|
|
Academic Article
|
Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
|
|
Academic Article
|
Botulinum toxin therapy for cervical dystonia.
|
|
Academic Article
|
Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.
|
|
Academic Article
|
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study.
|
|
Academic Article
|
Therapies in Parkinson's disease.
|
|
Academic Article
|
Long-term evaluation of deep brain stimulation of the thalamus.
|
|
Academic Article
|
Stiff-person syndrome: an autoimmune disease.
|
|
Academic Article
|
Orthostatic tremor: an association with essential tremor.
|
|
Academic Article
|
Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis.
|
|
Academic Article
|
Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome.
|
|
Academic Article
|
Treatment of advanced Parkinson's disease.
|
|
Academic Article
|
Is history of depression a contraindication to treatment with tetrabenazine?
|
|
Academic Article
|
Botulinum toxin injection for congenital muscular torticollis presenting in children and adults.
|
|
Academic Article
|
Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease.
|
|
Academic Article
|
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.
|
|
Academic Article
|
Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders.
|
|
Academic Article
|
Therapeutic uses of botulinum toxin.
|
|
Academic Article
|
Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
|
|
Academic Article
|
Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
|
|
Academic Article
|
Treatment of dystonia.
|
|
Academic Article
|
Potential outcome measures and trial design issues for multiple system atrophy.
|
|
Academic Article
|
A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
|
|
Academic Article
|
Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment.
|
|
Academic Article
|
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.
|
|
Academic Article
|
Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.
|
|
Academic Article
|
Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial.
|
|
Academic Article
|
A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome.
|
|
Academic Article
|
Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm.
|
|
Academic Article
|
Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-up.
|
|
Academic Article
|
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
|
|
Academic Article
|
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.
|
|
Academic Article
|
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.
|
|
Academic Article
|
Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies.
|
|
Academic Article
|
Flu-like symptoms following botulinum toxin therapy.
|
|
Academic Article
|
Diagnosis and treatment of psychogenic parkinsonism.
|
|
Academic Article
|
Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
|
|
Academic Article
|
Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease.
|
|
Academic Article
|
Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?
|
|
Academic Article
|
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
|
|
Academic Article
|
Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease.
|
|
Academic Article
|
Respiratory disorders associated with dystonia.
|
|
Academic Article
|
Emerging therapies for Parkinson's disease.
|
|
Academic Article
|
Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations.
|
|
Academic Article
|
Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders.
|
|
Academic Article
|
Botulinum toxin in the treatment of dystonic tics.
|
|
Academic Article
|
Use of botulinum toxin in the treatment of hand dystonia.
|
|
Academic Article
|
Surgical treatment of Parkinson's disease.
|
|
Academic Article
|
Symptomatic and functional outcome of surgical treatment of cervical dystonia.
|
|
Academic Article
|
Post-traumatic movement disorders: effect of the legal system on outcome.
|
|
Academic Article
|
Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response.
|
|
Academic Article
|
Complications and limitations of drug therapy for Parkinson's disease.
|
|
Academic Article
|
Effects of pallidotomy on gait and balance.
|
|
Academic Article
|
Treatment options for Parkinson's disease.
|
|
Academic Article
|
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.
|
|
Academic Article
|
Dystonia: medical therapy and botulinum toxin.
|
|
Academic Article
|
Treatment of cervical dystonia with botulinum toxin.
|
|
Academic Article
|
The effect of deep brain stimulation on quality of life in movement disorders.
|
|
Academic Article
|
Tetrabenazine in the treatment of hyperkinetic movement disorders.
|
|
Academic Article
|
An update on the treatment of Parkinson's disease.
|
|
Academic Article
|
Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
|
|
Academic Article
|
Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease.
|
|
Academic Article
|
Current approaches to the treatment of Parkinson's disease.
|
|
Academic Article
|
Treatment of hyperkinetic movement disorders.
|
|
Academic Article
|
Treatment of dysautonomia associated with Parkinson's disease.
|
|
Academic Article
|
Transcutaneous electrical stimulation (TENS) for psychogenic movement disorders.
|
|
Academic Article
|
Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN?, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia.
|
|
Academic Article
|
Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome.
|
|
Academic Article
|
Analysis of CYP2D6 genotype and response to tetrabenazine.
|
|
Academic Article
|
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
|
|
Academic Article
|
Long-term efficacy and safety of botulinum toxin injections in dystonia.
|
|
Concept
|
Physical Therapy Modalities
|
|
Concept
|
Genetic Therapy
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Chelation Therapy
|
|
Concept
|
Electric Stimulation Therapy
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Behavior Therapy
|
|
Concept
|
Withholding Treatment
|
|
Concept
|
Electroconvulsive Therapy
|
|
Concept
|
Treatment Failure
|
|
Academic Article
|
Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(?)) injections in blepharospasm.
|
|
Academic Article
|
Zolpidem improves tardive dyskinesia and akathisia.
|
|
Academic Article
|
Flu-like symptoms and associated immunological response following therapy with botulinum toxins.
|
|
Academic Article
|
An update on tardive dyskinesia: from phenomenology to treatment.
|
|
Academic Article
|
Medical treatment of dystonia.
|
|
Academic Article
|
The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond.
|
|
Academic Article
|
Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases.
|
|
Academic Article
|
Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.
|
|
Academic Article
|
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease.
|
|
Academic Article
|
Treatment of dystonia.
|
|
Academic Article
|
Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
|
|
Academic Article
|
Animal models of Parkinson's disease: a gateway to therapeutics?
|
|
Academic Article
|
Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy).
|
|
Academic Article
|
IncobotulinumtoxinA (Xeomin?) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated.
|
|
Academic Article
|
Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease.
|
|
Academic Article
|
Myorhythmia: phenomenology, etiology, and treatment.
|
|
Academic Article
|
Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE).
|
|
Academic Article
|
The therapeutic potential of cannabinoids for movement disorders.
|
|
Academic Article
|
Movement disorders in catatonia.
|
|
Academic Article
|
Restless legs syndrome: clinical presentation diagnosis and treatment.
|
|
Academic Article
|
A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease.
|
|
Academic Article
|
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
|
|
Academic Article
|
Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome.
|
|
Academic Article
|
Therapeutic Developments for Tics and Myoclonus.
|
|
Academic Article
|
Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine.
|
|
Academic Article
|
New and emerging medical therapies in Parkinson's disease.
|
|
Academic Article
|
Botulinum Toxin for the Treatment of Tremor and Tics.
|
|
Academic Article
|
Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
|
|
Academic Article
|
Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.
|
|
Academic Article
|
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
|
|
Academic Article
|
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
|
|
Academic Article
|
Neuropsychological outcomes from constant current deep brain stimulation for Parkinson's disease.
|
|
Academic Article
|
Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients.
|
|
Academic Article
|
Dopamine depleters in the treatment of hyperkinetic movement disorders.
|
|
Academic Article
|
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
|
|
Academic Article
|
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.
|
|
Academic Article
|
Treatment of blepharospasm with apraclonidine.
|
|
Academic Article
|
Thalamic DBS with a constant-current device in essential tremor: A?controlled clinical trial.
|
|
Academic Article
|
Apraclonidine in the treatment of ptosis.
|
|
Academic Article
|
Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.
|
|
Academic Article
|
Parkinson disease: Exenatide - a drug for diabetes and Parkinson disease?
|
|
Academic Article
|
Treatment options for chorea.
|
|
Academic Article
|
Immunologic treatment of Parkinson's disease.
|
|
Academic Article
|
Correction to: Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
|
|
Academic Article
|
Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study.
|
|
Academic Article
|
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
|
|
Academic Article
|
Treatable inherited rare movement disorders.
|
|
Academic Article
|
Deutetrabenazine for the treatment of Huntington's chorea.
|
|
Academic Article
|
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
|
|
Academic Article
|
Botulinum Toxin for the Treatment of Hand Tremor.
|
|
Academic Article
|
Does Added Objective Tremor Monitoring Improve Clinical Outcomes in Essential Tremor Treatment?
|
|
Academic Article
|
Pathogenesis-targeted therapeutic strategies in Parkinson's disease.
|
|
Academic Article
|
Botulinum toxin for the treatment of tremor.
|
|
Grant
|
Clinical center for the study of neuroprotection from PD
|
|
Academic Article
|
Targeting a-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics.
|
|
Academic Article
|
Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.
|
|
Academic Article
|
Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.
|
|
Concept
|
Molecular Targeted Therapy
|
|
Concept
|
Cell- and Tissue-Based Therapy
|
|
Academic Article
|
Juvenile parkinsonism: Differential diagnosis, genetics, and treatment.
|
|
Academic Article
|
Psychogenic (Functional) Movement Disorders.
|
|
Academic Article
|
Immunogenicity Associated with Botulinum Toxin Treatment.
|
|
Academic Article
|
Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study.
|
|
Academic Article
|
Reader response: High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy.
|
|
Academic Article
|
Reply to Comment on Re-Visiting Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491.
|
|
Academic Article
|
Treatment of tics associated with Tourette syndrome.
|
|
Academic Article
|
Treatment of Tardive Dyskinesia.
|
|
Academic Article
|
Treatment of Movement Disorders.
|
|
Academic Article
|
Parkinson disease and the immune system - associations, mechanisms and therapeutics.
|
|
Academic Article
|
Parkinson's disease: etiopathogenesis and treatment.
|
|
Academic Article
|
Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments.
|
|
Academic Article
|
Reply to: "Toward a Personalized Approach to Parkinson's Cell Therapy".
|
|
Academic Article
|
Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies.
|
|
Academic Article
|
Recent advances in understanding and treatment of Parkinson's disease.
|
|
Academic Article
|
Botulinum Neurotoxin Injections in Childhood Opisthotonus.
|
|
Academic Article
|
Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal.
|
|
Academic Article
|
Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette Syndrome.
|
|
Academic Article
|
Treatment of dystonia and tics.
|
|
Academic Article
|
Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-na?ve subjects.
|
|
Academic Article
|
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
|
|
Academic Article
|
Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.
|
|
Academic Article
|
Association of clinical outcomes and connectivity in awake versus asleep deep brain stimulation for Parkinson disease.
|
|
Academic Article
|
How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson's disease?
|
|
Academic Article
|
Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX?) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis.
|
|
Academic Article
|
Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact.
|
|
Academic Article
|
Botulinum toxin treatment in parkinsonism.
|
|
Academic Article
|
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial.
|